Arthur D. Collins, Jr. Decision Medical Welcomes Art Collins
Retired Chairman and CEO, Medtronic, Inc.
Art Collins currently is a member of the Board of Directors of Alcoa, Inc., The Boeing Company, Cargill, Inc., and US Bancorp. He also serves as a managing partner of Acorn Associates, LLC, and a senior advisor to Oak Hill Capital Partners.
After serving 16 years as a senior executive at Medtronic, Inc., 14 of which were as the company’s chairman & CEO or president & COO, Mr. Collins retired in 2008. He started his career at Medtronic in 1992 as executive vice president and president of Medtronic International. Medtronic is the largest medical technology company in the world with annual revenues of about $29 billion. Conducting business in more than 120 countries, Medtronic’s employment currently exceeds 92,000.
Mr. Collins joined Medtronic from Abbott Laboratories where he had been corporate vice president with responsibility for Abbott’s worldwide diagnostic business units since 1986. He began his 14-year career with Abbott in 1978 as manager of Corporate Planning and Development, and he moved to the Diagnostics Division a year later where he subsequently held a number of general management positions in the United States and Europe. Before joining Abbott, Mr. Collins served as an officer in the United States Navy. He later joined Booz, Allen & Hamilton as a consultant in Chicago. While a consultant, he conducted major assignments in the areas of business strategy development, marketing, organization planning, financial analysis, and financial systems design.
Mr. Collins received a Bachelor of Science degree and a Doctor of Laws honorary degree from Miami University in Oxford, Ohio. He also holds a Master of Business Administration degree from the Wharton School of the University of Pennsylvania where he was a member of the undergraduate faculty. He has served as a member of the Board of Overseers of the Wharton School and the Board of Visitors for the Farmer School of Business at Miami University. Mr. Collins also was the chairman of AdvaMed, the medical technology industry association, and has served on the boards of numerous governmental and civic organizations, including the President’s Export Council.
Robert A. Ingram
General Partner, Hatteras Venture Partners
Mr. Ingram joined the firm of Hatteras Venture Partners as a General Partner on January 24, 2007. Hatteras Venture Partners is a venture capital firm that invests in early stage life science companies in the southeast United States.
Mr. Ingram began his career in the pharmaceutical industry as a professional sales representative and rose through a series of roles with increasing responsibility to ultimately become CEO/Chairman of GlaxoWellcome. He co-led the merger and integration that formed GlaxoSmithKline, the world’s second largest pharmaceutical company. Upon reaching the mandatory retirement age of 60, he was asked by the Board to serve as Vice Chairman Pharmaceuticals, GSK, which he did until January 1, 2010, at which time he became Strategic Advisor to the Chief Executive Officer, GlaxoSmithKline plc.
He serves as Chairman of Elan Corporation plc. and as Lead Director of Valeant Pharmaceuticals International and Cree, Inc. He is also a member of the Board of Directors of Edwards Lifesciences Corporation.
In addition to his professional responsibilities, Mr. Ingram was asked by former US President George H.W. Bush to form and chair the CEO Roundtable on Cancer. He is a member of numerous other civic and professional organizations. In January 2004, Bob was awarded the Martin Luther King, Jr. Legacy Award for International Service. On July 27, 2006, he was appointed by President George W. Bush to the National Institutes of Health, National Cancer Advisory Board.
Mr. Ingram is a member of the Boards for the James B. Hunt Jr. Institute for Educational Leadership and Policy, H. Lee Moffitt Cancer Center, CEO Roundtable on Cancer, Research Triangle Institute and Chairman, GlaxoSmithKline Foundation. He serves as Chairman of Research Triangle Foundation of North Carolina and is on the Advisory Board, Leonard D. Schaeffer Center for Health Policy & Economics, University of Southern California.
Mr. Ingram graduated from Eastern Illinois University with a Bachelor of Science degree in Business Administration.
Keith C. Valentine
President, Chief Operating Officer, and Director, SeaSpine
Keith C. Valentine serves as President, Chief Executive Officer and as a director of SeaSpine. Prior to joining SeaSpine, Mr. Valentine served as President and Chief Operating Officer of NuVasive, Inc. from January 2007 to January 2015 and as President from December 2004 to January 2007, prior to which he served in various senior executive roles in Marketing, Development and Operations since joining NuVasive in 2001. Previously, Mr. Valentine served as Vice President of Marketing at ORATEC Interventions, Inc., a medical device company acquired by Smith & Nephew PLC, and spent eight years in various roles with Medtronic Sofamor Danek including, Vice President of Marketing for the Rods Division and Group Director for the BMP Biologics program, the Interbody Sales Development Effort, and International Sales and Marketing. Mr. Valentine received a Bachelor of Business Administration in Management and Biomedical Sciences from Western Michigan University.
Robert J. Whalen
For over 50 years Mr. Whalen has successfully managed high-technology businesses that have profitably produced products and systems that were transformative in their markets. He has held senior executive management positions in advanced technology corporations such as Titan, Martin Marietta, Lockheed Martin, and Alcoa. In addition, he has started and sold two successful technology-based companies. His proven experience and knowledge in the core sciences combined with the practical experience of taking technologies from the lab to the field is unsurpassed.
Some of the major programs in missile development and production led by Mr. Whalen include:
In the Day/Night fire control area, programs led by Mr. Whalen include:
Additional programs have included: MEAD, RADARS, Pave Penny (deployed on F10, F15, F10) and LST/SCAM (deployed on FA18).
Mr. Whalen holds a Bachelor of Science in Mechanical Engineering from Polytechnic Institute of Brooklyn and was conferred an honorary Doctorate of Philosophy in Engineering by the Florida Board of Regents.